English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNew research published in the journal Function identifies NKCC1, the protein responsible for moving sodium, potassium and chloride into cells, to be a cause of disease and dysfunction throughout the body. NKCC1 is encoded by the gene SLC12A2. Human and…
Tag: Lung Disease
Aging Limits Lung Cells’ Ability to Regenerate after Injury
A new study in mice explores the effect of aging on the regenerative properties of lung cells after lung injury. The study is published in the American Journal of Physiology-Lung Cellular and Molecular Physiology. It was chosen as an APSselect article for November.
Healthy Lung Month: Know these pulmonary fibrosis risk factors
October is Healthy Lung Month, an apt time to educate the public about the importance of protecting our lungs against mold, airborne pollutants and smoking – which put hundreds of thousands of Americans at higher risk for pulmonary fibrosis (PF).
‘Heat-not-burn’ Alternative to E-cigarettes May Harm Heart
A new review suggests “heat-not-burn” tobacco devices may threaten cardiovascular health. The review is published ahead of print in the American Journal of Physiology-Heart and Circulatory Physiology.
New Research Bolsters Link between Prenatal Smoking and Impaired Lung Development
Babies born to mothers who smoked during pregnancy are more likely to suffer from impaired lung development. They are also more susceptible to developing lung diseases such as asthma and chronic obstructive pulmonary disease (COPD).
Researchers Identify “Druggable” Signaling Pathway that Stimulates Lung Tissue Repair
Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have identified a cellular pathway that can be targeted with a naturally occurring drug to stimulate lung tissue regeneration, which is necessary for recovery from multiple lung injuries. The findings, which were published today in Nature Cell Biology, could lead to better therapies for patients with lung disease, including acute respiratory distress syndrome (ARDS) due to COVID-19.
Pulmonary Fibrosis Awareness Month Highlights Realities of Rare Disease
September’s Pulmonary Fibrosis Awareness Month shares crucial realities and insights about the rare disease, its symptoms and helpful resources provided by the Pulmonary Fibrosis Foundation to educate the public about this devastating disease which impacts over 200,000 Americans.
American Thoracic Society/CSL Behring Research Award in ARDS Announced
The ATS Research Program is pleased to announce the new ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome or ARDS. The award will provide $50,000 in funding for one year.
New Clinical Practice Guidelines on Non-Invasive Ventilation in Chronic Stable Hypercapnic COPD;
A subcommittee of the American Thoracic Society Assembly in Sleep and Respiratory Neurobiology has released new clinical practice guidelines to help advise clinicians on the optimal management of patients with chronic obstructive pulmonary disease (COPD) and chronic hypercapnia. Hypercapnia is the buildup of carbon dioxide in the bloodstream.
NIH harnesses AI for COVID-19 diagnosis, treatment, and monitoring
NIH has launched an ambitious effort to use artificial intelligence, computation, and medical imaging to enable early disease detection, inform successful treatment strategies, and predict individual disease outcomes of COVID-19.
Press Register Now; ATS 2020 Virtual Starts Aug. 5
Join us on Aug. 5-10 2020 for ATS 2020 Virtual, when the American Thoracic Society will host a mix of live and pre-recorded sessions in pulmonary, critical care, and sleep medicine. Press are invited to attend (see press guidelines) and may register now. Same day registration will be available during the meeting.
Rutgers Experts Available to Discuss Smoking and Vaping Effects on COVID-19 Patients
Smoking and vaping-related lung injuries create an underlying medical condition that can make people more susceptible to respiratory infections like the flu and COVID-19, according to experts at Rutgers New Jersey Medical School’s department of emergency medicine. “Both COVID-19 and…
Chest X-Rays in Emergency Rooms Can Help Predict Severity of COVID-19 Illness in Young and Middle-aged Adults
Chest X-rays performed on young and middle-aged adults with COVID-19 when they arrive at the emergency room can help doctors predict who is at higher risk of severe illness and intubation, Mount Sinai researchers report.
Clinicians Warn of the Dangers of Equating COVID-19 with High Altitude Pulmonary Edema
Early reports of COVID-19 symptoms and the compelling need to quickly identify treatment options and curb the growing number of critically ill patients have led to erroneous and potentially dangerous comparisons between COVID-19 and other respiratory diseases like high altitude pulmonary edema, or HAPE.
First Official ATS Practice Guidelines for Sarcoidosis Cover Diagnosis and Detection
New guidance is available for physicians who must go through a number of steps to provide a probable diagnosis of sarcoidosis – an inflammatory disease that affects the lungs, lymph glands, and other organs.
Impaired Blood Clotting May Explain Higher COVID-19 Risk
A new review suggests that higher-than-normal levels of an enzyme involved in blood clot prevention may be a common risk factor for developing COVID-19—a respiratory disease caused by the novel coronavirus SARS-CoV-2—in some populations. The review is published in Physiological Reviews.
ECMO Physicians Offer Guidance in the Context of Resource-scarce COVID-19 Treatment
Rapidly escalating numbers of COVID-19 patients suffering from respiratory failure threaten to overwhelm hospital capacity and force healthcare providers into making challenging decisions about the care they provide. Of particular interest is the role of ECMO – extracorporeal membrane oxygenation, a form of life support for patients with advanced lung disease – to support critically ill patients in the current pandemic.
Coronavirus’ Binding Action May Also Cause Kidney Damage and Infertility; Researchers Consider Potential Treatment Paths
Article title: COVID-19 infection and mortality – A physiologist’s perspective enlightening clinical features and plausible interventional strategies Authors: Zaid A. Abassi, Karl Skorecki, Samuel Noam Heyman, Safa Kinaneh, Zaher Armaly From the authors: “Cleavage of the S-glycoprotein by furin and its…
Mount Sinai Physicians the First in U.S. Analyzing Lung Disease in Coronavirus (COVID-19) Patients from China
Findings from CT scans provide new insight that could lead to quicker diagnosis
Researchers Identify Molecule Cluster That Improves Mucus Hydration in Cystic Fibrosis
Article title: Inhibition of ATP hydrolysis restores airway surface liquid production in cystic fibrosis airway epithelia Authors: Catharina van Heusden, Brian Button, Wayne H. Anderson, Agathe Ceppe, Lisa C. Morton, Wanda K. O’Neal, Hong Dang, Neil E. Alexis, Scott H.…
‘Are Noncommunicable Diseases Communicable?’ Rutgers Experts Available to Discuss Paper in Science Today
New Brunswick, N.J. (Jan. 16, 2020) – Rutgers professors Maria Gloria Dominguez-Bello and Martin J. Blaser are available to discuss a paper in the journal Science today on whether diseases long thought to be noncommunicable – such as cardiovascular diseases, cancer…
NTM Infections on the Rise Nationally; Women and Elderly Most Affected
The number of people newly infected each year and the number of people living with nontuberculous mycobacterial lung disease appears to be increasing, especially among women and those 65 and older, according to new research published online in the Annals of the American Thoracic Society.
Maternal Antibiotic Treatment May Harm Preemies’ Lungs
New research in mice suggests that exposure to antibiotics before birth may impair lung development in premature infants. The study, the first to explore the gut-lung axis in prematurity, is published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology and was chosen as an APSselect article for December.
E-cigarettes Boost Infection Risk by Blocking Action of Immune Cells
A new study finds that e-cigarette vapor weakens the mobility and function of immune cells designed to fight infection. This reduced ability may increase the risk of bacterial illnesses in people who vape. The research is published ahead of print in the American Journal of Physiology—Cell Physiology.
Mount Sinai Researchers Develop Novel Method to Identify Patterns Among Patients With Multiple Chronic Conditions
A study by researchers at Icahn School of Medicine at Mount Sinai proposes a novel method for identifying patterns in the frequency and cost of multiple chronic conditions (MCC).
Expert Available to Discuss Dangers of Vaping and Associated Lung Illness
WHO: Keith S. Naunheim, MD, Vallee L. Melba Willman Professor and Chief of Cardiothoracic Surgery at Saint Louis University (SLU), and past president of The Society of Thoracic Surgeons WHY: The U.S. Food and Drug Administration and the U.S. Centers…
Experts @UCSDHealth & @UCSDMedSchool available to discuss dangers of #vaping and lung disease
In August, the Centers for Disease Control (CDC) issued a warning about a growing epidemic — lung injury caused by vaping. There have been more than 380 cases reported nationwide, with half of these patients requiring intensive care, and at…
Experts @UCSDHealth & @UCSDMedSchool available to discuss dangers of #vaping and lung disease
In August, the Centers for Disease Control (CDC) issued a warning about a growing epidemic — lung injury caused by vaping. There have been more than 380 cases reported nationwide, with half of these patients requiring intensive care, and at…